$42.83
-0.540 (-1.25%)
At Close: Jul 31, 2026
LOS ANGELES, CA / ACCESSWIRE / September 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosc
LOS ANGELES, CA / ACCESSWIRE / September 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosc
Investors With Losses In Spruce Biosciences Inc Should Join The Schall Law Firm In An Investigation Into Securities Law Violations
11:00am, Wednesday, 11'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosc
LOS ANGELES, CA / ACCESSWIRE / September 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosc
Spruce Biosciences Inc May Have Violated Securities Regulations And Investors Are Invited To Help The Schall Law Firm's Inquiry
11:00am, Monday, 09'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosci
The Schall Law Firm Urges Stockholder Participation In An Investigation Into Whether Spruce Biosciences, Inc. Committed Securities Fraud
11:00am, Saturday, 07'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosci
LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosci
The Schall Law Firm Urges Investors With Losses In Spruce Biosciences Inc. To Reach Out About An Inquiry Into Possible Securities Fraud
11:00am, Thursday, 05'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosci
LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosci
LOS ANGELES, CA / ACCESSWIRE / September 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosci
Spruce Biosciences Inc May Have Engaged In Illegal Practices And Affected Investors Are Invited To Contact The Schall Law Firm
11:00am, Monday, 02'nd Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosci
LOS ANGELES, CA / ACCESSWIRE / September 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosci
Spruce Biosciences Inc Is Being Investigated For Fraud And The Schall Law Firm Seeks Investor Participation
11:00am, Saturday, 31'st Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Bioscien
LOS ANGELES, CA / ACCESSWIRE / August 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Bioscien
Spruce Biosciences Is Being Inquired Into For Securities Fraud And Investors Are Encouraged By The Schall Law Firm To Take Part
11:00am, Thursday, 29'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Bioscien
Sign In
Buy SPRB